Aeterna completes enrollment for Phase II trial of lung cancerAeterna Zentaris has completed patient recruitment for its European multi-center Phase …
Novartis' Prexige has been taken off the market and UK doctors instructed to immediately stop prescribing it following several instances …
Poor value for money and improvements in the NHS have forced a number of planned private sector schemes to be …
UK pharma companies have until next July to conform to new rules aimed at making their relations with patient groups …
Doctors and clinicians will have access to a free new computer program that can help them reduce the number of …
Johnson & Johnson is to re-model its business operations into more customer-focused units, including a 'comprehensive care' arm that will …
GlaxoSmithKline will update US labelling for its diabetes treatment Avandia to state there is no conclusive evidence linking it to …
NICE has rejected Schering-Plough's Remicade as a treatment for the debilitating form of spinal inflammation known as ankylosing spondylitis.The Institute …
Merck looks set to pay $4.9 billion in a settlement for the thousands of people claiming injury after taking its …
Acambis has struck a deal with Sanofi Pasteur to co-develop and co-market a vaccine for West Nile disease, a serious …
New research has been undertaken to help more women reach senior roles in the pharmaceutical industry. The study, carried out …
BioView and Transgenomic sign distribution agreement BioView has licensed Transgenomic to distribute its family of scanning and analysis workstations in …
A drug used to prevent excessive blood loss during surgery could be causing deaths in patients, and has been suspended …
The European launch of new diabetes drug Galvus could be delayed by up to six months after small but significant …
The Conservative party says the NHS must be freed from 'political tinkering' in order for it to focus on improving …
The role of pharmacists as frontline NHS clinicians is being promoted by the work of a key committee. The government …
A key target to cut waiting times for operations looks unlikely to be hit by the NHS, prompting the government …